American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

Exploring the value of same-day permanent pacemaker implantation after TAVR
Temporary pacemakers are typically used for at least 24 hours before care teams consider implanting a permanent device. New research out of Canada suggests it may make sense in certain scenarios to go straight to the permanent pacemaker.
Widespread use of polypills could prevent up to 72 million heart disease deaths
Targeting high-risk patients with single-pill combination therapies, also known as polypills, could change healthcare on a global scale, according new data published in the Journal of the American College of Cardiology.
AI software takes cardiac risk assessments to another level
Allen Taylor, MD, thinks AI-powered plaque evaluations can make a substantial impact on patient care.
How pairing SAVR with additional heart surgeries affects mortality risk
When older patients undergo SAVR with concomitant procedures, it increases their short- and long-term risks of mortality. Should this influence care teams to consider more transcatheter treatments?
First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve
A heart team chose to perform BASILICA before valve-in-valve TAVR in a failed Lotus device to help minimize the risk of complications. These scenarios will likely grow more and more common as patients outlive their TAVR valves.

Links to all the American College of Cardiology late-breaking studies for ACC.23

Here are links to more information on every late-breaking presentation at ACC.23.

ACC 2023 program chair Douglas Drachman, MD, explains the top takeaways from the American College of Cardiology meeting. #ACC #ACC23

Key takeaways from the ACC 2023 annual meeting

ACC.23 Program Chair Doug Drachman, MD, explains what he saw as some of the key takeaways from the American College of Cardiology (ACC) 2023 annual meeting.

Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research

High dosage of blood thinners lowers 30-day morbidity for hospitalized COVID-19 patients

For patients who were hospitalized, but not yet in the ICU, those randomly assigned a higher-dose of anticoagulants had lower 30-day mortality risk than those on a lower dose.

An attendee tries out a hands-on TEE simulator in a packed GE Healthcare booth at ACC.23. Photo by Dave Fornell

ACC.23 emerges as a return to normalcy for the cardiology community

Attendance was higher for the conference in 2023 than in 2019, the last year before the COVID-19 pandemic.

New American College of Cardiology President B. Hadley Wilson shares his goals for the future

The veteran interventional cardiologist told Cardiovascular Business he sees potential in the ACC's ability to grow both nationally and internationally in the next year.

Keto-like diets linked to increased risk of high cholesterol, heart disease

New research, presented during ACC.23/WCC in New Orleans, has raised fresh concerns about the potential cardiovascular-related drawbacks of high-fat, low-carbohydrate diets.

Atul Verma, MD, head of cardiology at McGill University Health Centre

Day 3 at ACC.23 features late-breaking studies on pulsed-field ablation, other new technologies

The third and final day of ACC.23 featured a key update on Medtronic's pulsed-field ablation technology and many other late-breaking clinical studies.

ACC 2023 ACC.23 American College of Cardiology

Day 2 at ACC.23 features late-breaking studies on TEER, TAVR, EHR alerts and much more

Catch up on the biggest news that came out of the second day of ACC.23 in New Orleans.

American College of Cardiology (ACC)

Exploring the value of same-day permanent pacemaker implantation after TAVR

Widespread use of polypills could prevent up to 72 million heart disease deaths

AI software takes cardiac risk assessments to another level

How pairing SAVR with additional heart surgeries affects mortality risk

First patient treated with BASILICA before valve-in-valve TAVR in a mechanically-expanded valve